{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:45:12Z","timestamp":1793169912012,"version":"4.5.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Qiqihar Science and Technology Plan Joint Guidance Project","award":["LSFGG-2023050"],"award-info":[{"award-number":["LSFGG-2023050"]}]},{"name":"Fundamental Research Funds for Education Department of Heilongjiang Province","award":["2021-KYYWF-0364"],"award-info":[{"award-number":["2021-KYYWF-0364"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:sec>\n            <jats:title>Backgrounds:<\/jats:title>\n            <jats:p>Chronic hepatitis (CH) refers to liver inflammation lasting at least 6 months caused by various factors, significantly impacting patients\u2019 daily lives. <jats:italic toggle=\"yes\">Paeoniae Radix Rubra<\/jats:italic> (CS) is a classic blood-activating and stasis-dissolving herb known for its protective effects on the liver. This research seeks to investigate the underlying mechanisms by which CS treat CH, employing network pharmacology and molecular docking.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The active constituents of CS for CH treatment were identified through the TCMSP database. Targets associated with CH were gathered from GeneCards, the Therapeutic Target Database, and OMIM databases. The intersecting genes between these targets and the components of CS were considered potential therapeutic targets. Protein\u2013protein interaction analysis was performed with the use of the STRING database and Cytoscape software, leading to the identification of core targets. These core targets underwent KEGG and GO enrichment analysis, and the top 10 pathways were chosen for building a drug\u2013compound\u2013target\u2013pathway\u2013disease\u2019 network. Finally, molecular docking was utilized to evaluate the binding affinities between the compounds and the core targets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From the TCMSP database, 29 compounds were screened, and 101 potential intersection targets of CS for treating CH were identified. The protein\u2013protein interaction network analysis revealed that the core targets included EGFR, HSP90AA1, SRC, TNF, ALB, ESR1, CASP3, PTGS2, ERBB2, and FGF2. Pathway analysis indicated that CS\u2019s treatment of CH is mainly associated with the pathway in cancer. Molecular docking results indicated that Paeoniflorin and Baicalin exhibited strong binding affinity with EGFR and HSP90AA1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This research uncovers the possible mechanisms of CS in CH treatment, offering new avenues for future studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040796","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T21:02:47Z","timestamp":1733778167000},"page":"e40796","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The therapeutic effects of Paeoniae Radix Rubra on chronic hepatitis through network pharmacology and molecular docking"],"prefix":"10.1097","volume":"103","author":[{"given":"Chunlei","family":"Yu","sequence":"first","affiliation":[{"name":"The Institute of Medicine, Qiqihar Medical University, Qiqihar City, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical Pathological Diagnosis Center, Qiqihar Medical University, Qiqihar City, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zou","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Qiqihar Medical University, Qiqihar City, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbo","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pathology, Qiqihar Medical University, Qiqihar City, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8200-7818","authenticated-orcid":false,"given":"Siwen","family":"Pan","sequence":"additional","affiliation":[{"name":"College of Pathology, Qiqihar Medical University, Qiqihar City, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/hep.27323","article-title":"Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.","volume":"61","author":"Rehermann","year":"2015","journal-title":"Hepatology"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging.","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cld.2010.07.001","article-title":"Pathology of chronic Hepatitis B and chronic hepatitis C.","volume":"14","author":"Fiel","year":"2010","journal-title":"Clin Liver Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis.","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets.","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment.","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cld.1014","article-title":"Histological Grading and Staging of Chronic Hepatitis.","volume":"17","author":"Krishna","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5472\/MMJsi.2901.05","article-title":"Histopathologic diagnosis of chronic viral hepatitis.","volume":"29","author":"\u00c7elikel","year":"2016","journal-title":"Marmara Medical Journal"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fphar.2020.00531","article-title":"Paeoniflorin, a natural product with multiple targets in liver diseases-a mini review.","volume":"11","author":"Ma","year":"2020","journal-title":"Front Pharmacol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3892\/mmr.2014.2868","article-title":"Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor-beta\/Smad pathway in rats.","volume":"11","author":"Huang","year":"2015","journal-title":"Mol Med Rep"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3389\/fphar.2020.01054","article-title":"Efficacy, chemical constituents, and pharmacological actions of radix paeoniae rubra and radix paeoniae alba.","volume":"11","author":"Tan","year":"2020","journal-title":"Front Pharmacol"},{"key":"R12-20250504","first-page":"595","article-title":"Research progress on chemical constituents of Paeoniae Rubra Radix and their pharmacological effects.","volume":"46","author":"Xiao-hua","year":"2015","journal-title":"Chin Tradit Herbal Drugs (in Chinese)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"155616","DOI":"10.1016\/j.phymed.2024.155616","article-title":"Paeoniflorin mitigates MMP-12 inflammation in silicosis via Yang-Yin-Qing-Fei Decoction in murine models.","volume":"129","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"116925","DOI":"10.1016\/j.lfs.2019.116925","article-title":"A review for the anti-inflammatory effects of paeoniflorin in inflammatory disorders.","volume":"237","author":"Xin","year":"2019","journal-title":"Life Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.lfs.2017.04.019","article-title":"Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect.","volume":"180","author":"Yu","year":"2017","journal-title":"Life Sci"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"9475074","DOI":"10.1155\/2017\/9475074","article-title":"Antithrombotic effect and mechanism of radix paeoniae rubra.","volume":"2017","author":"Xie","year":"2017","journal-title":"Biomed Res Int"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"110505","DOI":"10.1016\/j.biopha.2020.110505","article-title":"A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects.","volume":"130","author":"Zhou","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"153669","DOI":"10.1016\/j.phymed.2021.153669","article-title":"Paeoniflorin: a neuroprotective monoterpenoid glycoside with promising anti-depressive properties.","volume":"90","author":"Wang","year":"2021","journal-title":"Phytomedicine"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.fitote.2014.10.009","article-title":"Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1\u03b1 through mTOR-dependent pathway.","volume":"99","author":"Zhao","year":"2014","journal-title":"Fitoterapia"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.saa.2017.04.034","article-title":"Application of near-infrared spectroscopy for the rapid quality assessment of Radix Paeoniae Rubra.","volume":"183","author":"Zhan","year":"2017","journal-title":"Spectrochim Acta Part A"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e202401119.","DOI":"10.1002\/cbdv.202401119","article-title":"Paeoniae radix rubra:a review of ethnopharmacology, phytochemistry, pharmacological activities, therapeutic mechanism for blood stasis syndrome, and quality control.","volume":"21","author":"Fan","year":"2024","journal-title":"Chem Biodiversity"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"112331","DOI":"10.1016\/j.phytochem.2020.112331","article-title":"Characterization of phytochemicals in the roots of wild herbaceous peonies from China and screening for medicinal resources.","volume":"174","author":"Yang","year":"2020","journal-title":"Phytochem"},{"key":"R23-20250504","first-page":"1569","article-title":"Analyze and compare activities of polysaccharide form rhizoma chuanxiong and radix paeoniae rubra.","volume":"34","author":"Zhang","year":"2011","journal-title":"Zhong Yao Cai"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"117987","DOI":"10.1016\/j.jep.2024.117987","article-title":"A systematic review and meta-analysis of the anti-tumor effects of Paeoniae Radix Rubra in animal models.","volume":"326","author":"Wang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.intimp.2005.01.013","article-title":"The screening and isolation of an effective anti-endotoxin monomer from Radix Paeoniae Rubra using affinity biosensor technology.","volume":"5","author":"Genfa","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"14634","DOI":"10.3390\/ijms131114634","article-title":"Radix Paeoniae Rubra and Radix Paeoniae Alba Attenuate CCl4-induced acute liver injury: an ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) based metabolomic approach for the pharmacodynamic study of Traditional Chinese Medicines (TCMs).","volume":"13","author":"Wang","year":"2012","journal-title":"Int J Mol Sci"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1645\/GE-1994.1","article-title":"Paeoniflorin: a monomer from traditional Chinese medical herb ameliorates schistosoma japonicum egg-induced hepatic fibrosis in mice.","volume":"95","author":"Li","year":"2009","journal-title":"J Parasitol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1017\/S0031182011001065","article-title":"Paeoniflorin attenuates schistosomiasis japonica-associated liver fibrosis through inhibiting alternative activation of macrophages.","volume":"138","author":"Chu","year":"2011","journal-title":"Parasitology"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fct.2013.04.030","article-title":"Paeoniflorin protects against ANIT-induced cholestasis by ameliorating oxidative stress in rats.","volume":"58","author":"Zhao","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1341651","DOI":"10.3389\/fphar.2024.1341651","article-title":"Chishao (Paeoniae Radix Rubra) alleviates intra-hepatic cholestasis by modulating NTCP in rats.","volume":"15","author":"Sun","year":"2024","journal-title":"Front Pharmacol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"8684","DOI":"10.3390\/molecules16108684","article-title":"Hepatoprotective action of Radix Paeoniae Rubra aqueous extract against CCl4-induced hepatic damage.","volume":"16","author":"Li","year":"2011","journal-title":"Molecules"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1875-5364(13)60037-0","article-title":"Traditional Chinese medicine network pharmacology: theory, methodology and application.","volume":"11","author":"Li","year":"2013","journal-title":"Chi J Natural Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s43440-021-00227-1","article-title":"Pharmacological properties of baicalin on liver diseases: a narrative review.","volume":"73","author":"Yang","year":"2021","journal-title":"Pharmacol Rep"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2015.04.008","article-title":"Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection.","volume":"97","author":"Garc\u00eda-Ni\u00f1o","year":"2015","journal-title":"Pharmacol Res"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: a review.","volume":"19","author":"S\u00e1nchez-Valle","year":"2012","journal-title":"Curr Med Chem"},{"issue":"Supplement_1","key":"R36-20250504","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1677\/erc.1.01032","article-title":"The epidermal growth factor receptor family.","volume":"12","author":"Bazley","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer.","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol Oncol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3390\/cancers14102379","article-title":"Disentangling ERBB signaling in breast cancer subtypes-a model-based analysis.","volume":"14","author":"Kemmer","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"G50","DOI":"10.1152\/ajpgi.00434.2013","article-title":"Epiregulin promotes the emergence and proliferation of adult liver progenitor cells.","volume":"307","author":"Tomita","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.01.007","article-title":"Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor.","volume":"128","author":"Svegliati-Baroni","year":"2005","journal-title":"Gastroenterology"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.26898","article-title":"Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.","volume":"59","author":"Fuchs","year":"2014","journal-title":"Hepatology"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3233\/CBM-190169","article-title":"Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease.","volume":"29","author":"Cai","year":"2020","journal-title":"Cancer Biomarkers"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12964-020-00604-y","article-title":"FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.","volume":"18","author":"Shi","year":"2020","journal-title":"Cell Commun Signal"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2147\/OTT.S159432","article-title":"Expression of HSP90AA1\/HSPA8 in hepatocellular carcinoma patients with depression.","volume":"11","author":"Xiang","year":"2018","journal-title":"OncoTargets and Therapy"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41419-023-06091-6","article-title":"USP14 governs CYP2E1 to promote nonalcoholic fatty liver disease through deubiquitination and stabilization of HSP90AA1.","volume":"14","author":"Wei","year":"2023","journal-title":"Cell Death Dis"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/cells9030558","article-title":"Src inhibition attenuates liver fibrosis by preventing hepatic stellate cell activation and decreasing connective tissue growth factor.","volume":"9","author":"Seo","year":"2020","journal-title":"Cells"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1158\/0008-5472.CAN-11-2260","article-title":"Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src\/PI3K\/Akt pathway.","volume":"71","author":"Liu","year":"2011","journal-title":"Cancer Res"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00281-022-00910-2","article-title":"TNF in the liver: targeting a central player in inflammation.","volume":"44","author":"Tiegs","year":"2022","journal-title":"Semin Immunopathol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41419-020-2411-6","article-title":"TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice.","volume":"11","author":"Wandrer","year":"2020","journal-title":"Cell Death Dis"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MEG.0b013e3283632189","article-title":"Clinical significance of a scoring formula of liver injury for the preoperative evaluation of patients with liver cirrhosis.","volume":"26","author":"Liu","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"9202128","DOI":"10.1155\/2022\/9202128","article-title":"Network pharmacology-based exploration on the intervention of qinghao biejia decoction on the inflammation-carcinoma transformation process of chronic liver disease via MAPK and PI3k\/AKT Pathway.","volume":"2022","author":"Cheng","year":"2022","journal-title":"Biomed Res Int"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","article-title":"Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis.","volume":"157","author":"Widjaja","year":"2019","journal-title":"Gastroenterology"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"117516","DOI":"10.1016\/j.jep.2023.117516","article-title":"Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK\/NF-\u03baB signaling pathway.","volume":"321","author":"Lan","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"e39176","DOI":"10.1016\/j.heliyon.2024.e39176","article-title":"Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation.","volume":"10","author":"Zheng","year":"2024","journal-title":"Heliyon"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/ijms17010030","article-title":"EGFR signaling in liver diseases.","volume":"17","author":"Komposch","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:07:28Z","timestamp":1746320848000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":55,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040796","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}